Medical Research News

RSS

Researchers launch space travel study with $1.2M NASA grant

The final frontier may be no further than Manhattan, Kan., as a team of Kansas State University researchers launches a project funded by a $1.2 million grant from the National Aeronautics and Space Administration.

24 Aug 2010

Study finds multi-modal hemispheric based program improves participant's educational outcomes

A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes. The study, "The Effect of Hemispheric Specific Remediation Strategies on the Academic Performance Outcome of Children With ADD/ADHD," was conducted by a research team including, Gerry Leisman, Robert Melillo, Sharon Thum, Mark Ransom, Michael Orlando, Christopher Tice, and Frederick Carrick. The study appears in the current issue of the International Journal of Adolescent Medicine and Health.

24 Aug 2010

Discovery of Hsp90 protein's pattern of motion paves way for new drug target in cancer therapy

The protein Hsp90 plays a significant role in the survival of cells that are exposed to stress. Researchers at the Technische Universitaet Muenchen (TUM) uncovered this protein's mode of operation some time ago - but now Hsp90 has surprised even the experts with an unexpected pattern of motion. The results are published in the current online issue of the renowned science journal PNAS and may help researchers discover specific cancer medication.

24 Aug 2010

EPA selects Precision Antibody to develop monoclonal antibodies for 'Crypto' intestinal parasite

Precision Antibody™ announced today its selection by the United States Environmental Protection Agency (EPA) to develop monoclonal antibodies to two species of Cryptosporidium, an intestinal parasite that has emerged over the past 20 years as one of the most common causes of waterborne illness in the United States.

24 Aug 2010

NJIT researchers awarded 15 new U.S. patents for research programs

NJIT researchers were awarded 15 new U.S. patents this past year, increasing the total number of issued patents for NJIT to 97. More than 150 applications are in process. With projected research expenditures greater than $90 million for 2010-11, NJIT ranks as a leader in size and growth of research programs among technological universities. The patents were awarded from July 1, 2009-June 30, 2010. Specifics follow.

24 Aug 2010

National Fibromyalgia Association, RemedyMD partner to build fibromyalgia research registry

The National Fibromyalgia Association has partnered with RemedyMD® to provide a national database that will aggregate data from a wide variety of sources to provide a complete disease registry for fibromyalgia research. It offers new hope to sufferers since this will represent the first time that researchers have the opportunity to look at all data relevant to fibromyalgia in order to identify patterns which lead to more effective diagnosis and treatment.

24 Aug 2010

Novartis presents 2010 Immunology prizes at 16th International Congress of Immunology in Kobe

The Novartis 2010 Immunology Prizes were presented at the 16th International Congress of Immunology in Kobe, Japan. Since 1992, the Novartis Prizes for Immunology have been awarded every third year for outstanding contributions to basic and clinical immunology. The prizes recognize individual achievement and provide financial support for further research by the recipients. The prizes are a major feature of the triennial International Congress of Immunology.

24 Aug 2010

NARSAD announces 2010 Independent Investigator grants for innovative researchers

NARSAD announced its 2010 Independent Investigator grants totaling in excess of $4.1 million, which will support 42 innovative researchers at the leading edge of discovery within neuroscience and psychiatry. Since 1987 NARSAD has awarded more than $261.6 million in 3,832 grants to 3,132 scientists around the world.

24 Aug 2010

CPF continues partnership with American Thoracic Society to fund Pulmonary Fibrosis research

The Coalition for Pulmonary Fibrosis (CPF) and the American Thoracic Society (ATS), the world's leading professional organization for pulmonary, critical care and sleep physicians, today announced that the CPF will again partner with the ATS to continue to fund Pulmonary Fibrosis (PF) research.

24 Aug 2010

Research on OGF-OGFr complex helps to understand pathobiology of diseases

Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the Opioid Growth Factor (OGF, [Met5]-enkephalin) and its receptor, OGFr, a clinically important system with potent antitumor properties, has controlled entry from the cytoplasm to the nucleus. The nucleocytoplasmic passage of OGF-OGFr is critical to cell proliferation and suggests that there are hierarchical levels of nuclear import.

24 Aug 2010

Berries help aging brain stay healthy

Scientists today reported the first evidence that eating blueberries, strawberries, and acai berries may help the aging brain stay healthy in a crucial but previously unrecognized way. Their study, presented at the 240th National Meeting of the American Chemical Society (ACS), concluded that berries, and possibly walnuts, activate the brain's natural "housekeeper" mechanism, which cleans up and recycles toxic proteins linked to age-related memory loss and other mental decline.

24 Aug 2010

Epilepsy Therapy Project, EF announce recipients of New Therapy Grants Program

The Epilepsy Therapy Project (ETP) and the Epilepsy Foundation (EF) today announced the latest grant recipients of its New Therapy Grants Program, a unique joint venture of the non-profit epilepsy organizations, to advance promising epilepsy research in clinical development. The grant awards, totaling approximately $200,000 in funding, will support an experimental gene therapy that directly targets epileptogenic brain tissue, as well as an electrode system that has the potential to improve the efficacy of surgical therapies for certain epilepsy syndromes.

24 Aug 2010

Study enhances use of stem cells for organ regeneration

Cindy Morrissey, President and CEO of Emerging Healthcare Solutions, Inc., called the results of a recent study on Friday an 'encouraging step' towards the use of stem cells to regenerate human organs.

24 Aug 2010

ArtVentive Medical Group signs development agreement with Medical Murray

ArtVentive Medical Group, Inc. announced the Company has signed a manufacturing, research and development agreement with Medical Murray Inc.. Medical Murray is a leader in medical device and product development including specialty manufacturing services.

24 Aug 2010

Physiotherapy after surgery reduces pain by 50% within 3-6 months

Most patients who receive physiotherapy after surgery experience that pain is reduced by a half within a few months. Most of them are free of pain after one to two years. This is the conclusion of a thesis presented at the University of Gothenburg, Sweden.

24 Aug 2010

Specific drugs can prevent lethal effects of Parkinson's disease: Research

Researchers at Johns Hopkins have shown that using specific drugs can protect nerve cells in mice from the lethal effects of Parkinson's disease. The researchers' findings are published in the August 22 issue of Nature Medicine.

24 Aug 2010

Researchers find new drug to treat circadian rhythm disorders

Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Medical Research Council (MRC) have successfully used a drug to reset and restart the natural 24 hour body clock of mice in the lab. The ability to do this in a mammal opens up the possibility of dealing with a range of human difficulties including some psychiatric disorders, jet lag and the health impacts of shift work.

24 Aug 2010

Research finds variation in sex chromosome may cause lupus in men

Genes reside along long chains of DNA called chromosomes. UCLA researchers have found that a variation in a gene on the sex chromosome X may enhance an immune response that leads to lupus in men.

24 Aug 2010

Alpha-synuclein gene silencing effective for treating neurodegenerative disorders: Research

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.

24 Aug 2010

Study finds high glucose level blocks infectious bacteria detection, affects immunity

Research led by the Warwick Medical School at the University of Warwick has found that unhealthy glucose levels in patients with diabetes can cause significantly more problems for the body than just the well-known symptoms of the disease such as kidney damage and circulation problems.

24 Aug 2010

Medical Research News

Researchers launch space travel study with $1.2M NASA grant

Study finds multi-modal hemispheric based program improves participant's educational outcomes

Discovery of Hsp90 protein's pattern of motion paves way for new drug target in cancer therapy

EPA selects Precision Antibody to develop monoclonal antibodies for 'Crypto' intestinal parasite

NJIT researchers awarded 15 new U.S. patents for research programs

National Fibromyalgia Association, RemedyMD partner to build fibromyalgia research registry

Novartis presents 2010 Immunology prizes at 16th International Congress of Immunology in Kobe

NARSAD announces 2010 Independent Investigator grants for innovative researchers

CPF continues partnership with American Thoracic Society to fund Pulmonary Fibrosis research

Research on OGF-OGFr complex helps to understand pathobiology of diseases

Berries help aging brain stay healthy

Epilepsy Therapy Project, EF announce recipients of New Therapy Grants Program

Study enhances use of stem cells for organ regeneration

ArtVentive Medical Group signs development agreement with Medical Murray

Physiotherapy after surgery reduces pain by 50% within 3-6 months

Specific drugs can prevent lethal effects of Parkinson's disease: Research

Researchers find new drug to treat circadian rhythm disorders

Research finds variation in sex chromosome may cause lupus in men

Alpha-synuclein gene silencing effective for treating neurodegenerative disorders: Research

Study finds high glucose level blocks infectious bacteria detection, affects immunity

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News